Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Gillin

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|May 14, 2018
3D treatment planning system-Varian Eclipse for proton therapy planningNarayan Sahoo, Falk Poenisch, Xiaodong Zhang, et al.
Cancer|March 26, 2011
Phase 2 study of high-dose proton therapy with concurrent chemotherapy for unresectable stage III nonsmall cell lung cancerJoe Y Chang, Ritsuko Komaki, Charles Lu, et al.
Cancer|January 26, 2011
Early findings on toxicity of proton beam therapy with concurrent chemotherapy for nonsmall cell lung cancerSamir Sejpal, Ritsuko Komaki, Anne Tsao, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 25, 2015
Robust optimization in intensity-modulated proton therapy to account for anatomy changes in lung cancer patientsHeng Li, Xiaodong Zhang, Peter Park, et al.
International Journal of Radiation Oncology, Biology, Physics|May 22, 2013
Phase 1 study of dose escalation in hypofractionated proton beam therapy for non-small cell lung cancerDaniel R Gomez, Michael Gillin, Zhongxing Liao, et al.
Medical Physics|August 3, 2015
Selective robust optimization: A new intensity-modulated proton therapy optimization strategyYupeng Li, Perttu Niemela, Li Liao, et al.
International Journal of Radiation Oncology, Biology, Physics|January 22, 2011
Toxicity and patterns of failure of adaptive/ablative proton therapy for early-stage, medically inoperable non-small cell lung cancerJoe Y Chang, Ritsuko Komaki, Hong Y Wen, et al.
Medical Physics|March 4, 2016
Motion-robust intensity-modulated proton therapy for distal esophageal cancerJen Yu, Xiaodong Zhang, Li Liao, et al.
International Journal of Radiation Oncology, Biology, Physics|January 24, 2007
Effect of anatomic motion on proton therapy dose distributions in prostate cancer treatmentXiaodong Zhang, Lei Dong, Andrew K Lee, et al.
Radiation Oncology (London, England)|July 21, 2019
Statistical evaluation of worst-case robust optimization intensity-modulated proton therapy plans using an exhaustive sampling approachZhiyong Yang, Heng Li, Yupeng Li, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|May 14, 2018
3D treatment planning system-Varian Eclipse for proton therapy planningNarayan Sahoo, Falk Poenisch, Xiaodong Zhang, et al.
Cancer|March 26, 2011
Phase 2 study of high-dose proton therapy with concurrent chemotherapy for unresectable stage III nonsmall cell lung cancerJoe Y Chang, Ritsuko Komaki, Charles Lu, et al.
Cancer|January 26, 2011
Early findings on toxicity of proton beam therapy with concurrent chemotherapy for nonsmall cell lung cancerSamir Sejpal, Ritsuko Komaki, Anne Tsao, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 25, 2015
Robust optimization in intensity-modulated proton therapy to account for anatomy changes in lung cancer patientsHeng Li, Xiaodong Zhang, Peter Park, et al.
International Journal of Radiation Oncology, Biology, Physics|May 22, 2013
Phase 1 study of dose escalation in hypofractionated proton beam therapy for non-small cell lung cancerDaniel R Gomez, Michael Gillin, Zhongxing Liao, et al.
Medical Physics|August 3, 2015
Selective robust optimization: A new intensity-modulated proton therapy optimization strategyYupeng Li, Perttu Niemela, Li Liao, et al.
International Journal of Radiation Oncology, Biology, Physics|January 22, 2011
Toxicity and patterns of failure of adaptive/ablative proton therapy for early-stage, medically inoperable non-small cell lung cancerJoe Y Chang, Ritsuko Komaki, Hong Y Wen, et al.
Medical Physics|March 4, 2016
Motion-robust intensity-modulated proton therapy for distal esophageal cancerJen Yu, Xiaodong Zhang, Li Liao, et al.
International Journal of Radiation Oncology, Biology, Physics|January 24, 2007
Effect of anatomic motion on proton therapy dose distributions in prostate cancer treatmentXiaodong Zhang, Lei Dong, Andrew K Lee, et al.
Radiation Oncology (London, England)|July 21, 2019
Statistical evaluation of worst-case robust optimization intensity-modulated proton therapy plans using an exhaustive sampling approachZhiyong Yang, Heng Li, Yupeng Li, et al.
Pageof 6